Free Trial

Colgate-Palmolive Company $CL Position Reduced by Robeco Institutional Asset Management B.V.

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Robeco Institutional Asset Management B.V. reduced its stake in Colgate-Palmolive Company by 20.3% during Q2, selling 562,296 shares and holding approximately 0.27% of the company worth about $200.9 million.
  • Colgate-Palmolive has received mixed ratings from analysts, with seven analysts rating it as a Buy and a consensus target price of $97.27, although several firms have recently lowered their target prices.
  • The company announced a quarterly dividend of $0.52 per share, representing an annual yield of 2.6%, scheduled for payment on November 14, with a payout ratio of 58.43%.
  • MarketBeat previews the top five stocks to own by November 1st.

Robeco Institutional Asset Management B.V. trimmed its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 20.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,210,555 shares of the company's stock after selling 562,296 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.27% of Colgate-Palmolive worth $200,939,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the stock. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $285,000. Vision Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $322,000. Autumn Glory Partners LLC raised its holdings in shares of Colgate-Palmolive by 67.4% during the first quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after purchasing an additional 3,586 shares during the period. Financial Gravity Asset Management Inc. acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $2,166,000. Finally, Penserra Capital Management LLC raised its holdings in shares of Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after purchasing an additional 8,515 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts have weighed in on CL shares. Citigroup dropped their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. JPMorgan Chase & Co. dropped their target price on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an "underweight" rating on the stock in a report on Thursday, September 25th. Finally, Morgan Stanley dropped their price objective on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Seven investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $97.27.

Check Out Our Latest Analysis on Colgate-Palmolive

Colgate-Palmolive Stock Down 1.2%

Colgate-Palmolive stock opened at $78.95 on Thursday. The stock has a market cap of $63.81 billion, a price-to-earnings ratio of 22.18, a PEG ratio of 4.16 and a beta of 0.34. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The company's 50-day moving average price is $83.69 and its two-hundred day moving average price is $88.50. Colgate-Palmolive Company has a 52 week low of $78.76 and a 52 week high of $102.61.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the company earned $0.91 EPS. On average, analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Secret Tech Stocks Wall Street Missed
Buy the Dip: 3 Healthcare Stocks Ready to Recover
3 Options Myths Costing You Money (Do This Instead)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines